Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Oncothyreon: $31 For Shares? Don't Believe The Hype
Seeking Alpha
Monday, November 28, 2011 - 11:40am
tags:
Oncothyreon
Pozen sells Treximet royalty rights for $75M
Yahoo/AP
Monday, November 28, 2011 - 11:39am
tags:
Pozen, Treximet
Gilead's Pharmasset Purchase Could Help Double Market Cap By 2020
Seeking Alpha
Monday, November 28, 2011 - 11:38am
tags:
Gilead, Pharmasset, M&A, hepatitis C, GSK, JNJ, Bristol-Myers Squibb, PSI-7977, Vertex, HIV
AstraZeneca Victory Over Iressa Labeling Is Appealed
Pharmalot
Monday, November 28, 2011 - 9:57am
tags:
AstraZeneca, Iressa, lung cancer
Abbott expands agreement with GSK to include additional cancer immunotherapy
Yahoo/Fly on the Wall
Monday, November 28, 2011 - 9:55am
tags:
Abbott Laboratories, GSK, cancer immunotherapy
New Patent Could Be Worth $6 A Share To Amgen
Forbes
Monday, November 28, 2011 - 9:55am
tags:
Amgen, patents, Enbrel, rheumatoid arthritis
Novartis receives European approval for blood pressure pill Rasitrio
Yahoo/AP
Monday, November 28, 2011 - 9:54am
tags:
Novartis, Europe, antihypertensives, Rasitrio
Vertex: competition fears hit hard
FT.com
Monday, November 28, 2011 - 9:53am
tags:
Incivek, Merck, JNJ, Vertex
Merck chairman to retire this week
Bizjournals.com
Monday, November 28, 2011 - 9:50am
tags:
Merck, Richard Clark
No new drugs? Blame Wall Street
CNN/Fortune
Monday, November 28, 2011 - 9:49am
tags:
innovation, patents, patent cliff
Medical marketing in legal battleground
Philadelphia Inquirer, PA
Sunday, November 27, 2011 - 12:10pm
tags:
legal, marketing
3 Rallying Healthcare Stocks With Bullish Short Trends
Seeking Alpha
Sunday, November 27, 2011 - 12:07pm
tags:
Biomarin, Questcor Pharmaceuticals, Medivation
Former executive sues KV Pharmaceutical
STL Today, MO
Sunday, November 27, 2011 - 12:03pm
tags:
KV Pharmaceutical, lawsuits
KV PHARMACEUTICAL DOWN 3.3%, SHARES SLIDE INTO THE RED (KV.A)
Zacks
Saturday, November 26, 2011 - 11:14am
tags:
KV Pharmaceutical
Takeda submits new drug application in the U.S. for Type 2 Diabetes Continue reading on Examiner.com Takeda submits new drug application in the U.S. for Type 2 Diabetes
Wall Street Journal
Saturday, November 26, 2011 - 11:08am
tags:
Takeda, alogliptin, metformin, diabetes
Pozen Enters into Purchase and Sale Agreement with CPPIB Credit Investments; Shares Rise 48% Pre-Market
Benzinga
Saturday, November 26, 2011 - 11:02am
tags:
Pozen
Questor Pharmaceuticals: Even In A Bad Market, Fantastic Growth Looks Attractive
Seeking Alpha
Saturday, November 26, 2011 - 11:00am
tags:
Questcor Pharmaceuticals
7 Black Friday Biotech Bargains
Motley Fool
Saturday, November 26, 2011 - 10:50am
tags:
Dendreon, Human Genome Sciences, GSK, Avanir, Exelixis, MannKind, Amarin, Vertex Pharmaceuticals
Amarin Omega-3 Medication
Investor's Business Daily
Saturday, November 26, 2011 - 10:46am
tags:
Amarin, AMR101, omega-3 fatty acid
Teva Pharmaceutical: Dividend Dynamo, or the Next Blowup?
Motley Fool
Saturday, November 26, 2011 - 10:44am
tags:
Teva Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.